Amgen Urges Ban on Cholesterol Drug Sales After Patent Win

Overview


William Gaede, Eric Hagen, Terry Ahearn, Bhanu Sadasivan, Shane Smith, Sarah Columbia, Nicole Clouse and Lauren Martin, who previously won a jury verdict that patents for client Amgen’s cholesterol drug were valid, urged a Delaware federal judge to levy a permanent injunction barring two competitors from selling versions of the drug.